Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Sector: Pharmaceutical Preparations
Industry: Real Estate - Services
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 51.40M shares outstanding
USRafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel.
The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate.
Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones.
The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Alan M. Grayson
Director and Director Nominee
David Polinsky
Chief Financial Officer
Howard S. Jonas
Chief Executive Officer, President, Founder & Executive Chairman
Mark N. Stein
Director and Director Nominee
Employees
22
Country
US
Sector
Real Estate
Website
rafaelholdings.com
Loading congressional disclosures…
based on 51.40M shares outstanding
US30d Avg
257.43K
60d Avg
189.73K
90d Avg
157.75K
